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ABSTRACT  
Importance. Surgical treatment can bring seizure remission in people with focal epilepsy, 
but requires careful selection of candidates.   
Objectives. To determine which preoperative factors are associated with post-operative 
seizure outcome. 
Design. We audited seizure outcome of 693 adults who had resective epilepsy surgery 
between 1990 and 2010 and used survival analysis to detect preoperatively identifiable risk 
factors of poor seizure outcome.  
Results. Seven factors were significantly associated with increased probability of recurrence 
of seizures with impaired awareness post-surgery: MRI findings (eg hazard ratio adjusted for 
other variables in the model 2.5; 95% CI 1.6 to 3.8 for normal MRI compared with 
hippocampal sclerosis (HS)), a history of secondarily generalised convulsive seizures (2.3; 
95% CI 1.7 to 3.0 for these seizures in the previous year vs never), psychiatric history (1.3; 
95% CI 1.1 to 1.7), learning disability (1.8; 95% CI 1.2 to 2.6), and extratemporal (vs 
temporal) surgery (1.4; 95% CI 1.02, 2.04). People with an older onset of epilepsy had a 
higher probability of seizure recurrence (1.01; 95% CI 1.00, 1.02) as did those who had used 
more anti-epileptic drugs (1.05; 95% CI 1.01, 1.09). Combinations of variables associated 
with seizure recurrence gave overall low probabilities of 5-year seizure freedom (eg a normal 
MRI and convulsive seizures in the previous year has a probability of seizure freedom at five 
years of approximately 0.19).  
Conclusions and Relevance. Readily identified clinical features and investigations are 
associated with reduced probability of good outcome and need consideration when planning 
presurgical evaluation.   
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INTRODUCTION 
Surgery is an option for people with focal epilepsy not controlled with antiepileptic drugs 
(AED). Numerous uncontrolled studies and two small randomised controlled trials[1;2] 
showed that, in appropriately selected people, surgery can bring prolonged remission and 
improved quality of life. Some individuals, however, do not attain seizure freedom[3] and 
careful selection is crucial. 
Since 1990, we have systematically evaluated our epilepsy surgery outcomes to clarify long-
term results and identify predictive factors, to help advise potential candidates. We 
previously estimated seizure freedom probability (ILAE class 1 or 2)[4] as 0.52 at 5 years 
and 0.47 at 10 years. We found that age at surgery, operation type and pathology were 
independent seizure recurrence predictors[3]. We have now extended the cohort and 
incorporated other potential predictors. 
Two recent studies predicted outcome using pre-identified pre-surgically available variables. 
The first[5] gave 0/1 scores for six predictors (seizure frequency, history of secondarily 
generalised tonic clonic seizures (SGTCS), MRI abnormality, epilepsy duration, intracranial-
EEG use, temporal or extratemporal resection), and found that the total score predicted 
outcome. The other used outcomes of nine predictors of which six remained following 
stepdown selection (sex, duration, seizure frequency, SGTCS, operation type and 
pathology) and constructed a nomogram to predict outcome[6]. These studies started with a 
few predefined predictors and did not consider many of the variables we incorporated. In 
another study of 121 people with temporal epilepsy, duration for <10 years, positive 
preoperative MRI, history of febrile seizures, not having SGTCS, and concordant EEG 
findings predicted good outcome[7].  
METHODS 
We identified long-term seizure outcome to the end of 2011 in consecutive people 
undergoing resective epilepsy surgery between February 1990 and November 2010. Two 
neurosurgeons specialized in epilepsy surgery carried out > 90% of operations. For people 
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having two surgical procedures for epilepsy (18 people), we censored data at the time of the 
second procedure. 
We searched contemporaneous medical records and notes from other hospitals people were 
attending for presence or absence of seizures with loss of awareness and classified 
outcome (ILAE outcome group 1 = entirely seizure free, outcome group 2 = auras only, 
outcome groups 3-6 = occurrence of seizures with loss of awareness)[4] for each 12 month 
period after surgery, ignoring seizures within four weeks of surgery. Data were 
supplemented by annual direct enquiry to individuals, primary care teams and next of kin by 
a neurologist and clinical manager[3]. Any discrepancies between sources were investigated 
with further inquiries. We aimed to establish potential risk factors of poor outcome 
(demographic details, results of preoperative investigations, clinical history, AED use, 
surgical procedures, psychiatric/psychological history) that were available preoperatively. 
Details are available in the supplementary methods. 
Analysis was performed using Stata 13.1. Cox proportional hazard regression was used to 
analyse time to event outcomes and compare the probability of a seizure impairing 
awareness (ILAE outcome group 3-6)[4] after surgery. Hazard ratios (HRs) were calculated 
with 95% CIs. The main multivariable analysis included adults who had resections (ie 
temporal resection or lesionectomy, extratemporal resection or lesionectomy) and a 
secondary analysis included only those who had temporal procedures. Informal comparison 
of univariable HRs between those with temporal and those with extratemporal procedures 
was performed. 
We checked proportionality for Cox regression. The main analysis included 371 seizure 
events and 27 potential predictor variables while those with temporal resections had 319 
seizure events.  
In the separate sections (as above, and A to F in table 1 and supplementary methods), we 
first performed univariable analysis and then separate manual backward stepwise 
multivariable analyses of each variable in the group which had p<0.2 on univariable analysis; 
this was to be inclusive and to make sure that every potential variable was tested in a 
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multivariable model. We then performed further manual backward stepwise multivariable 
analysis including all variables significant at p<0.2 in the separate subgroup (A to F) 
multivariable analyses. We used the Kaplan Meier method to estimate the probability of 
seizure recurrence at 2 and 5 years in different groups. Two predictors (the individual anxiety 
and depression scores from the preoperative Hospital Anxiety and Depression Scale; HADS) 
were only performed in 362 people so the final multivariable analysis was performed with 
and without these variables. 
We plotted predicted probability of seizure freedom based on the regression models for 
different combinations of covariates to help visualise the impact of covariates on seizure 
remission following surgery. We used the lincom command (linear combinations of 
estimators) in Stata to estimate hazard ratios of various linear combinations of risk factors 
based on the analysis. This was approved by the Research Ethics Committee as a service 
evaluation; individual consent was, therefore, not required.  
RESULTS 
We considered 734 adults, but excluded 23 who had hemispherectomy or palliative 
procedures, and 18 with insufficient preoperative data or loss to follow-up before the first 
year after surgery, leaving 693 people. In 1-22 years of follow-up (mean 10 years, median 10 
years) 371 had at least one seizure impairing awareness. Table 1 indicates demographics 
and the variables considered. The overall probabilities of remaining free of these seizures, 
together with the number of people followed for those durations, are shown in table 2 with 
higher probabilities following temporal resections. Table 3 shows the initial univariable 
analysis for all 18 variables significant at p<0.02 that were entered into subgroup 
multivariable analysis. 
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Table 1. Potential predictive variables (N=693 unless otherwise stated). (NO (%) 
unless otherwise stated) 
A. DEMOGRAPHY  
Age of onset of epilepsy, yrs, mean (SD) median 12.2 (9.2) 11 
Duration of epilepsy before surgery, yrs, mean (SD) median  21.9 (11.1) 20.6 
Female 379 (55) 
Handedness  
Right 592 (85) 
Left 83 (12) 
Ambidextrous 12 (1.7) 
Unknown 6 (0.9) 
B.  INVESTIGATIONS  
Intracranial electrodes used  108 (16) 
Pathology as defined by MRI  
HS 426 (61) 
Discrete pathologies (Dysembryoplastic neuroepithelial tumour (76), cavernoma 
(37), glioma (23), focal cortical dysplasia (17)) 
153 (22) 
Dual pathology 31 (4.5) 
Other (eg gliosis, non-specific, brain damage) 54 (7.8) 
Normal MRI 29 (4.2) 
Background EEG changes  
Concordant for hemisphere and lobe 169 (24) 
Contralateral discordant (ie any abnormality in contralateral hemisphere) 268 (39) 
Ipsilateral discordant (ie any abnormality in ipsilateral hemisphere but different 
lobe) 
44 (6.4) 
Normal 117 (17) 
Abnormal, location not indicated 49 (7.1) 
No videotelemetry, or no results available 46 (6.6) 
Interictal epileptiform discharges  
Concordant for hemisphere and lobe 282 (41) 
Contralateral discordant (ie any discharge in contralateral hemisphere, but 
ipsilateral predominance) 
247 (36) 
Ipsilateral discordant (ie any discharge in ipsilateral hemisphere but different 
lobe) 
63 (9.1) 
No interictal discharge recorded 47 (6.8) 
Abnormal, location not indicated 8 (1.2) 
No videotelemetry, or no results available 46 (6.6) 
EEG ictal onset  
Concordant for hemisphere and lobe 379 (55) 
Contralateral discordant (ie apparent onset in contralateral hemisphere) 97 (14) 
Ipsilateral discordant (ie apparent onset in ipsilateral hemisphere but different 
lobe) 
52 (7.5) 
No scalp EEG change 34 (4.9) 
No seizure recorded 42 (6.1) 
Abnormal, location not indicated 43 (6.2) 
No videotelemetry, or no results available 46 (6.6) 
MRI location of lesion  
Concordant with resection 625 (90) 
Discordant (any abnormality outside resected area) 39 (5.6) 
Normal MRI 29 (4.2) 
C.  CLINICAL HISTORY  
Prior neurological insult  52 (7.5) 
Prolonged early childhood convulsions (>20 minutes, aged five yrs or younger)  155 (22) 
History of status epilepticus  94 (14) 
First degree relative with history of epilepsy  75 (11) 
Head injury prior to epilepsy onset  
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No 584 (84) 
Minor head injury 68 (9.8) 
Clinically important head injury  18 (2.6) 
Unclear 23 (3.3) 
Previous secondarily generalised seizures  
Yes, in yr prior to surgery (or > 50% probability of occurring in yr prior to 
surgery) 
317 (46) 
Yes, but not in yr prior to surgery (or <50% probability) 204 (29) 
No 172 (25) 
Focal seizures with loss of awareness (LOA) in year prior to surgery (per 
month), median (IQR) 
8 (4,15) 
<4 focal seizures with LOA per month 172 (25) 
4 to <8 focal seizures with LOA per month 155 (22) 
8 to <15 focal seizures with LOA per month 186 (27) 
>15 focal seizures with LOA per month 180 (26) 
D.  AED USE  
AEDs at time of surgery (excluding prn drugs), mean (SD) median 2.3 (0.9) 2 
AEDs ever taken before surgery (including at time of surgery), mean (SD) 
median 
7.1 (2.7) 7 
E.  SURGICAL DETAILS  
Operation type  
Temporal resection 567 (82) 
Temporal lesionectomy 52 (7.5) 
Extratemporal resection 32 (4.6) 
Extratemporal lesionectomy 42 (6.1) 
Side of surgery  
Left 373 (54) 
Right 320 (46) 
Year in which the surgery was performed  
1994 or earlier 107 (15) 
1995 to 1998 164 (24) 
1999 to 2002 133 (19) 
2003 to 2006 135 (19) 
2007 to 2010 154 (22) 
F.  PSYCHIATRY AND PSYCHOLOGY  
Psychiatric history recorded 246 (35) 
Non-epileptic attack disorder prior to surgery 16 (2.3) 
Learning disability 39 (5.6) 
Preoperative verbal IQ   
Verbal IQ <70 16 (2.3) 
Verbal IQ >70 617 (89) 
Not tested or results not available 60 (8.7) 
Preoperative performance IQ   
Performance IQ <70 20 (2.9) 
Performance IQ >70 601 (87) 
Not tested or results not available 72 (10) 
Hospital Anxiety & Depression scale (HADs) anxiety scale preoperative 
(N=362) 
 
No symptoms of anxiety 199 (55) 
Some symptoms of anxiety  163 (45) 
HADs depression scale preoperative (N=362)  
No symptoms of depression 279 (77) 
Some symptoms of depression  83 (23) 
Legend: HS; Hippocampal sclerosis, LOA: loss of awareness  
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Table 2. Probability of remaining free of seizures causing loss of awareness (Kaplan 
Meier probabilities) at 5, 10 and 15 years after surgery in the whole cohort, in those 
who had temporal  surgery and in those with extratemporal surgery 
 
Probability of 
remaining 
seizure free 
at: 
Whole cohort 
(N=693) (95% CI) 
(Number at risk) 
Temporal lobe 
surgery (N=619) 
(95% CI) (Number 
at risk) 
Extratemporal  
surgery (N=74) 
(95% CI) (Number 
at risk) 
5 years 0.50 (0.46, 0.54) 
(284) 
0.52 (0.48, 0.56) 
(267) 
0.33 (0.22, 0.44) (17) 
10 years 0.45 (0.41, 0.49) 
(165) 
0.47 (0.43, 0.52) 
(158) 
0.26 (0.15, 0.38) (7) 
15 years 0.42 (0.38, 0.46) 
(71) 
0.45 (0.40, 0.49) 
(68) 
Not estimated  
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Table 3. Factors associated with seizure recurrence on initial univariable 
analysis (p<0.2) and which were entered into subgroup (A to F) analysis (n=693)   
 Univariable HR 
Predictive factors HR (95% CI) 
Age of onset of epilepsy (yrs) (HR for one yr increase)* 1.009 (0.998, 1.020) 
Pathology as predicted by MRI (vs HS)  
Dysembryoplastic neuroepithelial tumour, cavernoma, glioma or 
focal cortical dysplasia 
1.43 (1.11, 1.83) 
Dual pathology 1.83 (1.16, 2.90) 
Other pathology 2.01 (1.41, 2.85) 
Normal MRI 2.96 (1.94, 4.53) 
Background EEG changes (vs concordant)  
Contralateral discordant  1.50 (1.14, 1.98) 
Ipsilateral discordant  1.67 (1.07, 2.60) 
Normal 1.27 (0.91, 1.77) 
Abnormal, location not indicated 1.48 (0.96, 2.27) 
No videotelemetry, or no results available 1.69 (1.09, 2.60) 
Interictal epileptiform discharges (vs concordant)  
Contralateral discordant  1.35 (1.07, 1.71) 
Ipsilateral discordant  1.43 (0.99, 2.06) 
No interictal epileptiform discharges 0.88 (0.55, 1.41) 
Abnormal, location not indicated 1.91 (0.84, 4.34) 
No videotelemetry, or no results available 1.49 (0.99, 2.24) 
Use of intracranial electrodes 1.75 (1.35, 2.26) 
MRI location of lesion (vs concordant with resection)  
Discordant 1.18 (0.76, 1.83) 
Normal MRI 2.51 (1.65, 3.80) 
Prolonged childhood convulsions 0.72 (0.55, 0.93) 
History of status epilepticus 1.39 (1.06, 1.82) 
Previous secondarily generalised seizures (vs No)  
Yes, in yr prior to surgery  2.27 (1.72, 2.99) 
Yes, but not in the yr prior to surgery  1.37 (1.00, 1.88) 
Focal seizures with LOA in the year prior to surgery (vs <4)  
4 to <8 focal seizures with LOA per month 0.80 (0.59, 1.09) 
8 to <15 focal seizures with LOA per month 0.92 (0.69, 1.23) 
>15 focal seizures with LOA per month 1.12 (0.85, 1.48) 
AEDs taken at the time of surgery* 1.125 (0.996, 1.272) 
AEDs ever taken* 1.059 (1.020, 1.099) 
Extratemporal surgery (vs temporal) 1.84 (1.37, 2.47) 
Year in which surgery was performed (vs 2007 to 2010)  
1994 or earlier 1.04 (0.75, 1.44) 
1995 to 1998 0.76 (0.56, 1.03) 
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1999 to 2002 0.68 (0.49, 0.95) 
2003 to 2006 0.67 (0.48, 0.94) 
Psychiatric history recorded 1.39 (1.13, 1.71) 
Learning disability recorded 1.70 (1.15, 2.51) 
Non-epileptic attack disorder prior to surgery 1.54 (0.84, 2.80) 
Performance IQ (vs >70)  
Performance IQ <70 1.39 (0.80, 2.42) 
Not tested or results not available 1.37 (0.98, 1.91) 
*3 decimal places given for HRs for discrete variables to allow accurate estimation of 
changes greater than one 
Legend: LOA; loss of awareness. HS; Hippocampal sclerosis 
 
Multivariable analysis of each separate subgroup gave 14 variables with p <0.2 that were 
included in the final multivariable analyses. One variable, a history of status epilepticus, 
violated proportionality assumptions on univariable analysis, but inspection of the graphs 
suggested that this was due to three people with such a history who had a first seizure 
recurrence 13 to 16 years after surgery, when only 12 people were at risk; we thus kept this 
variable in the analysis unaltered. Duration of epilepsy prior to surgery was not significant in 
univariable analysis (HR 0.999; 95% CI 0.989, 1.008) and so was not considered in the 
multivariable analysis. The final multivariable analysis showed that MRI lesion, SGTCS 
history, extratemporal or temporal surgery, a psychiatric history, learning disability, age of 
epilepsy onset, and number of AEDs ever taken, were significantly related to the probability 
of postsurgical seizure recurrence (table 4).  
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Table 4. Multivariable predictors of probability of seizure recurrence in 693 people 
having resective epilepsy surgery.  
Predictive factors Adjusted for other variables in the 
final model 
 HR (95% CI) 
Age of onset of epilepsy (yrs) (HR for one yr 
increase)* 
1.012 (1.000, 1.024) 
Number of AEDs ever taken* 1.048 (1.008, 1.090) 
Pathology as predicted by MRI (vs HS)  
Dysembryoplastic neuroepithelial tumour, 
cavernoma, glioma or focal cortical dysplasia 
1.22 (0.91, 1.64) 
Dual pathology 1.79 (1.13, 2.84) 
Other pathology 1.71 (1.16, 2.52) 
Normal MRI 2.45 (1.57, 3.84) 
History of secondarily generalised seizures (vs 
never) 
 
Ever  1.47 (1.07, 2.01) 
In yr prior to surgery 2.26 (1.71, 2.99) 
Other history  
Psychiatric history (yes) 1.34 (1.08, 1.66) 
Learning disability (yes) 1.75 (1.17, 2.63) 
Extratemporal surgery (vs temporal) 1.44 (1.02, 2.04) 
Legend: HS; hippocampal sclerosis 
Higher HRs are associated with a worse outcome – ie a greater probability of seizure 
recurrence  
*3 decimal places given for HRs for discrete variables to allow accurate estimation of 
changes greater than one 
 
Those with HS did better than any other pathology groups and recurrence risk was over 
twice as high in those with normal MRI as in those with HS. The HR of those with discrete 
pathologies was above 1 but did not reach statistical significance (table 4). SGTCS showed 
a gradient with those who had SGTCS in the year prior to surgery having twice the risk of 
recurrence of those who never had them; those with SGTCS longer ago had intermediate 
risk. When HADS scores were included, neither anxiety nor depression was significant on 
multivariable analysis. 
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Combinations of variables 
Figure 1 shows the impact of preoperative variables on the probability of remaining free of 
seizures affecting awareness. Visual inspection of the graphs suggests that, compared with 
the best case scenario of probability of seizure freedom at 5 years following surgery of 
approximately 0.74, a normal MRI reduced this to about 0.48, SGTCS in the year prior to 
surgery to about 0.51, learning disability to about 0.59, a psychiatric history to about 0.66, 
and extratemporal surgery to about 0.63. A normal MRI and SGTCS in the last year was 
associated with a seizure freedom rate at 5 years of about 0.19 (figure 1B), reducing to 
<0.10 if there was also learning disability or extratemporal surgery (figure 1C).    
 
Linear combination of estimators showed that, compared with somebody with no history of 
SGTCS and with HS on MRI, the HR for an individual with SGTCS in the previous year and 
a normal MRI would be 5.5 (95% CI 3.3 to 9.3). Having extratemporal rather than temporal 
surgery would increase this HR to 8.0 (95% CI 4.4, 14.4). The addition of learning disability 
instead would increase it to 9.7 (95% CI 5.0, 19.0) and a psychiatric history instead to 7.4 
(95% CI 4.2 to 13.1). By extrapolation, individuals with recent SGTCS, normal MRI, 
extratemporal surgery, learning disability and a psychiatric history would have an 18-fold 
increased risk of post-surgical recurrence compared with individuals with no SGTCS, HS, 
temporal surgery and neither learning disability nor a psychiatric history. This would suggest 
an estimated probability of seizure freedom at 5 years of <1%; none in our cohort had all 
these characteristics. 
Temporal and extratemporal surgery 
Those having temporal surgery (N=619) had a longer duration of epilepsy prior to surgery 
(mean 22.3 years) than those with extratemporal surgery (N=74; mean 18.8 years). 
Those with extratemporal surgery had taken more AEDs at the time of surgery and ever. A 
greater percentage of those with temporal surgery had had prolonged childhood convulsions 
(24% vs 5.4% for those with extratemporal surgery). More with extratemporal surgery (23%) 
had had a prior head injury than those with temporal surgery (11%). Fewer with 
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extratemporal surgery had concordant results for background EEG abnormality, interictal or 
ictal onset; numbers are small for most categories in the group with extratemporal surgery. 
Those with extratemporal surgery were more likely to have had intracranial recordings (46% 
compared with 12%). More people with extratemporal surgery had lesionectomies (42; 57%) 
than those with temporal surgery (52; 8%). There was no difference in the groups in respect 
of a history of status epilepticus: 14% of those with temporal surgery and 11% of those with 
extratemporal surgery.   
The results of the multivariable analysis for those with temporal surgery was similar to the 
whole group (table 5).  
Table 5. Multivariable predictors of probability of seizure recurrence in 619 people 
who had temporal lobe procedures 
Predictive variable (N) HR (95% CI) 
Age at onset of epilepsy (yrs) (HR for one year increase)* 1.014 (1.002, 1.027) 
Pathology as predicted by MRI (vs HS; n=425)  
Dysembryoplastic neuroepithelial tumour, cavernoma, glioma 
or focal cortical dysplasia (105) 
1.09 (0.79, 1.49) 
Dual pathology (30) 1.71 (1.07, 2.76) 
Other pathology (34) 1.90 (1.24, 2.92) 
Normal MRI (25) 2.55 (1.60, 4.07) 
History of secondarily generalized seizures (vs never; 
n=154) 
 
Ever (187) 1.48 (1.06, 2.08) 
In the year prior to surgery (278) 2.30 (1.70, 3.11) 
Psychiatric history (yes) (225) 1.42 (1.13, 1.77) 
Learning disability (yes) (31) 1.97 (1.24, 3.13) 
*3 decimal places given for HRs for discrete variables to allow accurate estimation of 
changes greater than one. 
 
The number of individuals with extratemporal surgery was insufficient for multivariable 
analysis. We had insufficient power to use interaction tests to investigate differences 
between the extratemporal and temporal groups, but informal inspection of univariable HRs 
(of potential predictor variables with at least 10% of people in each group positive) 
suggested that a history of status epilepticus had stronger association with seizure 
recurrence in those with extratemporal surgery (HR 2.84 vs 1.33 in the temporal group). Use 
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of intracranial electrodes was of lower prognostic significance in the group with 
extratemporal surgery (HR 1.03 vs 1.78 in the temporal group). Those who had a 
lesionectomy (rather than resection) did better in both groups, but the difference appeared 
more marked in the extratemporal group (HR 0.55 vs 0.93). The effect of age at epilepsy 
onset appeared different between groups, as did psychiatric history (HR 1.13 in the 
extratemporal group vs 1.47). Learning disability and a history of SGTCS in the year prior to 
surgery had similar effects in both groups.  
Epoch in which surgery was performed  
The epochs with relatively lower seizure free outcome (pre 1995 and 2007-2010 – Table 3) 
had a higher incidence of normal MRI at 7.5% and 7.8% respectively, compared with 1.8-
2.3% in the intervening years. In the 2007-2010 epoch there was a higher incidence of 
psychiatric comorbidity identified (45%), compared with 29-32% for pre1995-2002. 
DISCUSSION 
We have followed a large cohort who had epilepsy surgery at our centre over a long period.  
We included 27 variables in univariable, followed by multivariable, analysis to establish 
predictors of long-term outcome. Our results confirm that the probability of seizure 
recurrence following surgery is associated with MRI pathology and those with HS had the 
best outcome, and those with normal MRI did least well. We found that those with no history 
of SGTCS fared better. People with a learning disability or a psychiatric history had higher 
probability of seizure recurrence. We also found that extratemporal surgery was more 
strongly associated with seizure recurrence than temporal lobe surgery. 
In the current study we found that the overall probabilities of freedom from seizures with loss 
of awareness (ILAE class 1 or 2)[4] at 5 and 10 years were marginally lower than we 
previously estimated[3]. Previously a small study estimated the probability of seizure 
freedom of 0.67 at five years and 0.51 at ten years post-operatively[8]; the apparently higher 
rates of seizure freedom may be due to their more liberal definition of Engel group 
Bell  15 
 
classification I for seizure freedom, which incorporates the occurrence of some seizures with 
loss of awareness.  
Previous studies using a variety of methods following excision for HS found a probability of 
seizure freedom of 0.60[9] and 0.64[10] at 5 years and 0.43[9] and 0.65[11] at ten years and 
beyond; however, numbers were small, and two used questionnaires years after 
surgery[9;10]. It is likely that our results of people with temporal excision (75% had HS) are 
lower because of our practice of prospectively obtaining contemporaneous outcome data 
each year.  
Effect of pathology (MRI) 
We found that those with pathologies other than HS as detected by MRI were more likely to 
have seizure recurrence, and those with normal MRI did particularly badly. A study of 
neocortical resections found that pathology did not influence outcome, but a visible MRI 
lesion was associated with good outcome[12]. A study of temporal excision using survival 
analysis found that those with normal or ‘other’ pathology, as judged by a combination of 
histopathology and MRI findings, had a worse outcome than those with HS or foreign tissue 
lesions[13]. A recent study of 109 people with unremarkable MRI found 54% to be seizure 
free one year post-surgically[14]. Caveats with the interpretation of this study are that a more 
liberal definition of seizure freedom was used (Engel group 1) than in our studies and 
pathologies such as focal cortical dysplasia and dysembryoplastic neuroepithelial tumour 
would be expected to be detected by contemporary MRI. Other studies using outcome at 
specific time points found no effect of lesional vs non-lesional epilepsy (largely HS)[15] or of 
pathology (normal, gliosis or atrophy, hamartomas, arteriovenous malformations, non-
specific) almost 30 years post-surgery[16]. A review of surgery for epilepsy found that an 
abnormal MRI was associated with better outcome[17]. In conclusion, the weight of evidence 
is that if a discrete MRI-visible pathology, particularly HS, is resected, the chances of long-
term remission is better than if the MRI is normal.  
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History of SGTCS 
A history of SGTCS in our cohort had a gradient of effect. Those who had SGTCS in the 
year prior to surgery had the greatest risk of recurrence, and those with SGTCS longer ago 
had intermediate risk compared with those with no SGTCS, with similar effects in the whole 
cohort and those with temporal surgery, and those with extratemporal excision. A systematic 
review found that SGTCS before temporal surgery predicted poorer outcome[18]. Follow-up 
of 325 people with temporal resections found a similar gradient of response to ours[13]; it 
was speculated that this might reflect more widespread epileptogenic zones. In a smaller 
group with temporal excision, a history of SGTCS reduced the probability of being seizure 
free[11]. Others found that, in various extratemporal resections (in apparent contrast to our 
results), SGTCS were not associated with outcome; numbers were also small[19-21]. In 
conclusion, the occurrence of SGTCS is an adverse factor when predicting post-operative 
seizure freedom. 
Psychiatric history, learning disability and IQ 
People with a psychiatric diagnosis and those with learning disability had higher probability 
of recurrence, while IQ above or below 70 was not predictive; having a psychiatric disorder 
was previously shown in a subsection of this cohort to influence seizure outcome[22]. 
Another study found that people with low IQ were less likely to have surgery, but those who 
did achieved short term outcome comparable to those with higher IQ[23]. Some people with 
epilepsy perform progressively less well on IQ measures over time; this is not the same as 
having learning disability which, in this series, required it to be present from early childhood. 
A study found that IQ was an independent predictor of seizure freedom at two years, with 
more of those with IQ >70 seizure free[24]. In summary, psychiatric pathology and learning 
disability were associated with reduced chance of seizure remission, and the combination 
with extratemporal surgery, normal MRI and SGTCS was associated with very low chance, 
<1%, of remaining seizure free 5 years after surgery. 
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EEG findings and MRI concordance 
A systematic review found that unilateral interictal epileptiform abnormality on scalp-EEG 
was associated with good outcome after temporal resection, while scalp-EEG ictal 
characteristics were inconclusive[18]. We found no evidence that background, interictal or 
ictal EEG findings affected seizure recurrence. For this analysis, we regarded finding any 
contralateral spikes as indicating bilateral involvement, which is stricter than usual clinical 
interpretations.  
Multivariable analysis found no evidence that concordance of MRI with other findings 
predicted outcome, although few had discordant findings. It is the nature of the selection 
process to try to establish concordance, with the consequence that few people with 
discordant features on EEG or MRI go forward to surgery.  
Those needing intracranial EEG monitoring to define the site of onset of seizures had worse 
outcome on univariable analysis in the whole cohort and in those with temporal surgery; this 
was no longer significant once other variables were included, suggesting that other factors 
explain its apparent association. This is not a surprising finding and reflects the selection 
process for intracranial EEG; those who require invasive monitoring generally have a less 
clear-cut situation than those in whom intracranial EEG is not deemed necessary and hence 
might be expected to have poorer outcome. Others have shown no association between 
invasive recordings and outcome[19;25], while some found that, in certain situations, those 
who required intracranial monitoring had worse outcome[16;26;27]; differences in cohort 
selection, surgical procedures and small numbers may all influence findings.  
Era of surgery 
In univariable analysis the era of surgery was significant, with those having surgery between 
1999 and 2006 having a higher probability of seizure freedom than those operated since. 
This association, whilst weaker on multivariable analysis, suggests that people with less 
favourable prognostic features are now being taken forward for surgery. In particular, the 
pathology as predicted by MRI appears to be slightly different over the years with a lower 
percentage of people with HS, and a higher percentage of those with normal pathology 
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being having surgery in the earlier (before 1995) and later (after 2007) years, the years 
associated with poorer outcome. A likely explanation for this is that pre-1995 MRI was less 
sensitive than in later years, so some pathologies were not detected and in the current era, 
more challenging cases with normal optimal MRI and with evidence of psychiatric 
comorbidities are being considered for surgery. This underpins the importance of careful 
selection, whilst recognizing that some individuals with refractory epilepsy may wish to 
pursue surgical treatment, even if there is a low chance of seizure freedom.  
Number of AEDs ever taken 
A higher number of AEDs ever tried was associated with worse chance of a seizure free 
outcome. This had a positive correlation with duration of epilepsy (data not shown) and we 
interpret the number of AEDs taken to be a surrogate for epilepsy severity. 
Age of onset and duration of epilepsy 
For each year older at epilepsy onset, the probability of seizure recurrence increased by 1%. 
A study that dichotomised into age of onset <10 year and >20 years found that age of onset 
was not significantly associated with outcome after temporal surgery[28]. We did not find that 
duration of epilepsy prior to surgery was significant; and note that results from other groups 
have been inconsistent in this regard [6;7;13;15;19;29].  
Temporal and extratemporal surgery 
A review[17] reported that ‘55-70% of individuals undergoing temporal resection and 30-50% 
undergoing extratemporal resection become completely seizure-free’, although the 
difference was less marked in their own analysis (62% ‘good’ outcome – which includes >1 
year seizure free - for extratemporal resection and 69% for temporal). In contrast, using 
survival analysis, we found that at 5 years 33% remained seizure free in the extratemporal 
group compared with 52% in the temporal group (table 2). 
Two studies from the same Australian centre showed 5-year seizure freedom rates (Kaplan 
Meier) of 47.7% (95% CI 42, 53) following temporal resection [13] and 14.7% (95% CI 8, 23) 
following extratemporal resections[19]. A recent review found that extratemporal vs temporal 
surgery was inconsistently associated with outcome.[30]. Overall, it appears that 
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extratemporal surgery is associated with less chance of long-term remission, than is 
temporal lobe surgery. The latter group of course is associated with HS, which has the best 
outcome. This is not to say that extratemporal surgery should not be pursued as some have 
good long-term outcome, particularly if there is a well-defined discrete pathology evident on 
MRI.  
Combinations of covariates 
Our findings suggest that the combination of normal MRI, recent SGTCS and extratemporal 
surgery is associated with a low probability of good outcome, especially if there is also a 
psychiatric history or learning disability. If these findings are replicated, we should consider 
our advice to potential surgical candidates with these combinations.  
Complications of surgery are a very important aspect of outcome which we considered in our 
1990-2008 cohort[3] and more recently for the 1990-2014 cohort[31]. 
Limitations 
Our study has limitations. In this single centre observational series we obtained follow-up 
data on seizure outcome from records and enquiries to operated adults and their physicians 
and there is, therefore, the possibility of recall bias. Our practice is confined to adults, and so 
may not be generalizable to paediatric practice. Most had temporal excisions, so the results 
may also differ from those from centres with a different mix of procedures. A caveat is that 
the analysed EEG data were derived from written conclusions from presurgical EEG 
investigations that were previously undertaken. We recognize that a prospective and 
quantitative EEG evaluation might yield different results. Only about half our patients had 
HADS scores, limiting its use in analysis. There are many heterogeneous reasons why 
people did not have this performed including, in some cases, inability of the individual to 
understand the questions fully. There was no relationship between operation type and 
whether HADS scores were available. Additionally, HADS only assesses mood states in the 
previous week and may not reflect the individual’s overall affective state.   
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We also only considered seizure outcome and we fully recognise that other outcomes such 
as cognitive changes and quality of life are important; these are being currently analysed 
and will be reported separately.  
CONCLUSION 
Resective surgery is confirmed as an effective treatment for individuals with medication-
refractory focal epilepsy. We have shown that estimates of the probability of seizure freedom 
can be made from basic clinical and MRI data, and advice stratified (Fig 1). This should be 
discussed with individuals prior to embarking on intrusive, costly investigations, as some with 
low chance of a good result may elect not to undergo evaluation. A clinical judgment on the 
potential surgical need for an individual should, however, not be overruled by these 
estimates. A person with sufficiently severe seizures may elect to undergo a procedure 
despite a low probability of good outcome. 
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FIGURE LEGENDS 
Figure 1. Probability of seizure freedom in selected groups in the whole cohort (N=693). All 
assume age of onset of epilepsy of 11 years (median) and 7 (median) anti-epileptic drugs 
ever taken. 
 
A. Those with ‘best case scenario’: hippocampal sclerosis (HS), no secondarily 
generalised tonic-clonic seizures (SGTCS), temporal surgery, no psychiatric history, 
no learning disability compared with single significant prognostic features 
Legend: 
 
 
B. Normal MRI combined with single significant prognostic features  
Legend: 
 
C. Normal MRI, SGTCS in the last year, combined with significant prognostic features  
Legend: 
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